Hopes of India vaccine breakthrough


India may be a leading producer and exporter of vaccines, yet the government's immunisation programme fails to reach an estimated 28% of babies born there.

Now scientists in the country have come a step closer to developing a cheap vaccine that could help to save at least 60,000 children a year from death related to diarrhoeal disease.

Rotavac, if approved for commercial use would cost a 10th of the price of other vaccines on the market.

So could this be a game-changer for health outcomes in India, and the biotech industry? Shilpa Kannan reports.

Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.